Photo from wikipedia
Despite advances in ST-segment elevation myocardial infarction (STEMI) treatment, a sizeable minority of patients suffer poor outcomes even when treated with timely primary percutaneous intervention (PPCI). More potent P2Y12 inhibition… Click to show full abstract
Despite advances in ST-segment elevation myocardial infarction (STEMI) treatment, a sizeable minority of patients suffer poor outcomes even when treated with timely primary percutaneous intervention (PPCI). More potent P2Y12 inhibition improves clinical outcomes, however, oral agents have a slow
Keywords:
elevation myocardial;
primary percutaneous;
segment elevation;
percutaneous intervention;
myocardial infarction
Journal Title: Clinical Medicine
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Clinical Medicine
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!